Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

cmAngio® V1.0

K-Number: K232367 · 2023-10-05

Decision Date2023-10-05
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

cmAngio® V1.0 is a medical device manufactured by Curemetrix, Inc.. It received FDA 510(k) clearance on 2023-10-05 under approval number K232367. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the cmAngio® V1.0?

cmAngio® V1.0 is a medical device that received FDA 510(k) clearance on 2023-10-05. It is manufactured by Curemetrix, Inc.. The 510(k) number is K232367.

When was cmAngio® V1.0 approved by the FDA?

cmAngio® V1.0 received FDA 510(k) clearance on 2023-10-05, under approval number K232367.

What company makes cmAngio® V1.0?

cmAngio® V1.0 is manufactured by Curemetrix, Inc..

What is the FDA product code for cmAngio® V1.0?

The FDA product code for cmAngio® V1.0 is QIH.

Other Devices by Curemetrix, Inc.

Related Devices (Code: QIH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.